MOH — authorised 3 October 1980
- Marketing authorisation holder: B BRAUN
- Status: likely_approved
MOH authorised Bss on 3 October 1980
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 3 October 1980.
B BRAUN holds the Israeli marketing authorisation.